We went to our 20‑week scan full of hope and excitement, unaware of how drastically that morning would change our lives forever.
I was seeing my first baby on the ultrasound, imagining the babymoon we planned right after — a simple holiday before our world transformed.
But when the sonographer went quiet while looking at his tiny beating heart, I sensed fear that my mind was not ready to understand.
They told us something was wrong with his heart.
That moment, small and full of disbelief, was where our story took a turn we could never have imagined.
We were sent to a specialist hospital, expecting reassurance and instead given a series of shocking diagnoses.
Our little girl Helena wasn’t just facing a single issue.
She had a combination of severe congenital heart defects: Ebstein’s anomaly, pulmonary atresia, ASD, VSD, and a right aortic arch with an incomplete vascular ring — a rare and complex array of problems no parent should ever hear.
Ebstein’s anomaly alone — a condition in which the tricuspid valve is malformed and allows blood to flow backward, causing the right atrium to stretch — is rare and serious.
Pulmonary atresia, where the pulmonary valve fails to form properly, blocks blood from reaching the lungs.
ASD and VSD mean there were holes in her heart’s walls, letting oxygen‑poor and oxygen‑rich blood mix when they shouldn’t.
And a right aortic arch with an incomplete ring complicated her anatomy even further.
The explanation was clinical, but the reality was devastating: her heart was so malformed that survival would be difficult at best.
If she made it through birth at all, the doctors said, her chances of living beyond early childhood were slim — they expected she might only survive hours, not days or weeks.
The rest of my pregnancy became a fog of tests, scans, and fear.
I was intensely monitored, knowing that every step had to be carefully planned so that Helena could be born in a hospital capable of immediate intervention.
The science said her condition was among the most severe forms of congenital heart disease — a reality that meant her left side of the heart would never function the way it should.
Many babies diagnosed with similar conditions like Hypoplastic Left Heart Syndrome (HLHS) are known to require immediate, staged surgeries or may not survive without intervention; it’s a rare defect, accounting for a small percentage of all congenital heart anomalies.
The doctors prepared us that even with surgery, survival was uncertain.
In February 2024, Helena was born.
For a moment, it felt normal — I could hold her, her tiny fingers curled around mine, and I whispered that we loved her.
But the support team rushed her to the NICU, where she began her fight minutes after taking her first breath.
She surprised everyone by breathing well on her own at first, avoiding a ventilator for her first week of life.
Nurses would smile, commenting on how beautifully she was dressed even while on vapotherm oxygen support, but beneath it all was a heart strained far beyond what any newborn should endure.
Doctors hoped she might follow the single‑ventricle pathway — the Fontan route — a sequence of surgeries designed to reroute blood flow in hearts with only one functional ventricle.
But when she was 16 days old, she underwent her first surgery: three PDA stents were placed in her heart.
She came through that operation with resilience most would not have expected.
A week later, she pulled out her NG feeding tube and device support, proving she was stronger than even the machines around her.
At four weeks old, we finally brought her home.
That week — her first outside the hospital — was pure joy.
She smiled, cuddled, enjoyed her dummy, loved foot massages, and delighted in bath time.
Her brothers were thrilled to have her at home.
But the reality of her health was never far behind.
A week later, she struggled with breathing again and was readmitted to hospital.
She went from vapotherm back to CPAP support, something she hated with all her little might, as if even her discomfort was a battle she faced with clear will.
Weeks passed, and with every passing day in the respiratory ward, the tension mounted.
At six weeks into her hospital stay, she had a pulmonary hemorrhage — an event where bleeding into the lungs can be life‑threatening.
It was discovered that her heart had continued to stretch to fill her chest, compressing her fragile lungs and leaving little room for life to take hold.
The stents that once held hope were failing.
Doctors proposed urgent surgery — a conduit, an enlarged atrial septal opening, and a plication to reduce heart size.
But one more surgery carried one of the highest medical risks imaginable — the surgeons warned that Helena could die during the operation.
Not only that, but even if she survived, her heart could burst from pressure afterward, a relentless cycle no operation would ultimately fix.
We were told her valve couldn’t be repaired, meaning that even a successful surgery would not prevent the heart from stretching again and compressing her lungs anew.
In that room, everything we hoped for dissolved.
We had to make the most devastating choice a parent can ever face — to withdraw life support.
In my arms, Helena took her final breaths.
Her heart hero journey lasted only 14 weeks, but in that time, she taught us what it truly means to be brave.
We were told she was a miracle for surviving as long as she did, given how severe her heart conditions were.
The early detection at the 20‑week scan meant she had precious weeks with us that we would never have had otherwise — weeks full of love, of moments, of life beyond fear.
No matter how fragile her time was, it was ours — and she was ours.